Immune Heterogeneity Between Primary Tumors and Corresponding Metastatic Lesions and Response to Platinum Therapy in Primary Ovarian Cancer

CD3(+) and CD8(+) lymphocytes are well known prognostic markers in primary ovarian cancer. In contrast, the predictive value of the immune infiltrate concerning treatment response and the involvement of immune heterogeneity between primary and metastatic lesions are poorly understood. In this study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Dötzer, Katharina, Schlüter, Friederike, Schoenberg, Markus Bo, Bazhin, Alexandr V., Edler von Koch, Franz, Schnelzer, Andreas, Anthuber, Sabine, Grab, Dieter, Czogalla, Bastian, Burges, Alexander, Werner, Jens, Mahner, Sven, Mayer, Barbara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769550/
https://www.ncbi.nlm.nih.gov/pubmed/31455033
http://dx.doi.org/10.3390/cancers11091250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769550/
https://www.ncbi.nlm.nih.gov/pubmed/31455033
http://dx.doi.org/10.3390/cancers11091250

Ejemplares similares